Deviation Capital — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Human Biotech, Inc.Jun 2026SEC filingmedium confidence
Cambridge, US
Board seatDusan Perovic· per SEC Form D · $10M raise · filed Jun 2026
Walden RoboticsMay 2026 · $300M
Cambridge, US
Russell Louis Tedrake(Executive Officer, Director)Benjamin Clark Malloy Burchfiel(Executive Officer, Director)Kerri M. Fetzer-Borelli(Executive Officer)David Marvin Slaughter Johnson(Executive Officer)Adrien David Gaidon(Executive Officer)
BoardColin Beirne(Director)in
Co-investorsCalibrate VenturesMenlo VenturesNextView VenturesNVIDIAPrologis VenturesSamsung Ventures+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.